[1]
2018. Treatment interruption of biological drugs and tofacitinib in rheumatoid arthritis: A systematic review of case reports. Brazilian Journal of Pharmaceutical Sciences. 54, 4 (Dec. 2018), e17437. DOI:https://doi.org/10.1590/s2175-97902018000417437.